|
05 Apr 2007 |
Merck KGaA: Erbitux Meets Primary Endpoint in First-Line Phase III Head and Neck Cancer Study
|
|
05 Apr 2007 |
Merck KGaA: Erbitux Meets Primary Endpoint in First-Line Phase III Head and Neck Cancer Study
|
|
05 Apr 2007 |
Genzyme Files for Expanded Label for Campath(R) as First-Line Treatment for B-CLL Patients
|
|
05 Apr 2007 |
Crucell Announces Start of Rabies Phase I Antibody Cocktail Clinical Study in India four months after launching initial US Trial
|
|
05 Apr 2007 |
AVEO enters into Worldwide License and Development Agreement with Schering-Plough for AV-299, AVEO's Novel Anti-HGF Antibody
|
|
05 Apr 2007 |
Cerimon Pharmaceuticals Initiates ARREST UC-1, a Global Phase 2b Study of Basiliximab in Patients with Steroid-Refractory Ulcerative Colitis
|
|
04 Apr 2007 |
WILEX gives positive update of current pivotal Phase III trial of RENCAREX(R)
|
|
04 Apr 2007 |
Viventia Biotech initiates patient treatment for Vicinium(TM) Phase II bladder cancer trial
|
|
04 Apr 2007 |
Pharmexa and Affitech enter into an exclusive license agreement to promote Diabody technology
|
|
03 Apr 2007 |
Abbott Seeks U.S. and E.U. Regulatory Approval for HUMIRA(R) (Adalimumab) in Psoriasis
|
|
31 Mar 2007 |
Astellas Licenses Regeneron Velocimmune(R) Technology For Discovering Human Monoclonal Antibodies
|
|
30 Mar 2007 |
NEOPHARM Reports on FDA Meeting
|
|
30 Mar 2007 |
Anthrax Monoclonal Antibody Valortim(TM) Demonstrates Therapeutic Effect in New Primate Model of Established Anthrax Infection
|
|
30 Mar 2007 |
XTL Announces the Completion of Phase I Study with XTL-6865 in Patients with Chronic Hepatitis C
|
|
29 Mar 2007 |
MorphoSys and Astellas Enter Antibody Partnership - Deal Seals MorphoSys's Third Japanese Pharmaceutical Alliance
|
|
29 Mar 2007 |
Avastin Approved in Europe for First Line Treatment of Women with Metastatic Breast Cance
|
|
28 Mar 2007 |
Positive Interim Phase 2 Data Reported for VEGF Trap-Eye in Age-Related Macular Degeneration
|
|
28 Mar 2007 |
Seattle Genetics Announces Extension of Antibody-Drug Conjugate Collaboration with Genentech
|
|
27 Mar 2007 |
Herceptin receives positive opinion in Europe for use in combination with an aromatase inhibitor for the treatment of patients with HER2- and hormone receptor-positive metastatic breast cancer
|
|
27 Mar 2007 |
European Union CHMP Recommends Approval of First and Only Biologic Treatment for Pediatric Crohn's Disease: REMICADE(R)
|
|
24 Mar 2007 |
MedImmune Expands Anti-Interferon-Alpha Program by Initiating Phase 1 Trial in Patients With Psoriasis
|
|
24 Mar 2007 |
UCB Provides Update on Cimzia for Crohn's Disease and Rheumatoid Arthritis in the US
|
|
23 Mar 2007 |
Studies Show Mild Hyperthermia Enhances Antitumor Effects of Alfacell's ONCONASE(R)
|
|
23 Mar 2007 |
MilleGen and LFB Sign Research Partnership Agreement to Develop New Generation of Therapeutic Monoclonal Antibodies
|
|
23 Mar 2007 |
Amgen Discontinues Vectibix(TM) Treatment In PACCE Trial Evaluating Vectibix(TM) As Part Of Triple Combination Regimen
|
